Background: Identification of COPD patients with a rapid decline in FEV1 is of particular interest for prognostic and therapeutic reasons. Objective: To determine the expression of markers of inflammation in COPD patients with rapid functional decline in comparison to slow or no decliners. Methods: In COPD patients monitored for at least 3 years (mean ± SD: 5.8 ± 3 years) for lung functional decline, the expression and localization of inflammatory markers was measured in bronchial biopsies of patients with no lung functional decline (FEV1% + 30 ± 43 ml/year, n = 21), slow (FEV1% ml/year, − 40 ± 19, n = 14) and rapid decline (FEV1% ml/year, − 112 ± 53, n = 15) using immunohistochemistry. ELISA test was used for polym...
Introduction/Aim: Chronic obstructive pulmonary disease (COPD) is a significant and increasing publi...
Inflammatory biomarkers are considered by modern researchers as one of the best markers of effective...
Background: COPD phenotypes have been identified according to patient clinical characteristics and, ...
Background: Identification of COPD patients with a rapid decline in FEV1 is of particular interest f...
BACKGROUND: Identification of COPD patients with a rapid decline in FEV1 is of particular interest f...
Study objectives: Patients with COPD experience lower airway and systemic inflammation, and an accel...
SummaryBackgroundRecent studies show that COPD patients exhibit low-grade systemic inflammation, and...
Background: Early identification of patients with COPD and prone to more rapid decline in lung funct...
Background: Characterization of COPD patients with rapid lung functional decline is of interest for ...
Early identification of patients with COPD and prone to more rapid decline in lung function is of pa...
Introduction: There is considerable controversy on the possible predictors of lung function decline ...
Background:\ud Chronic Obstructive Pulmonary Disease (COPD) is a progressive disease resulting from ...
Background: Chronic obstructive pulmonary disease (COPD) is major cause of morbidity and mortality w...
Background: The major marker utilized to monitor COPD patients is forced expiratory volume in one se...
BACKGROUND: Change in forced expiratory volume in one second (FEV1) is important for defining severi...
Introduction/Aim: Chronic obstructive pulmonary disease (COPD) is a significant and increasing publi...
Inflammatory biomarkers are considered by modern researchers as one of the best markers of effective...
Background: COPD phenotypes have been identified according to patient clinical characteristics and, ...
Background: Identification of COPD patients with a rapid decline in FEV1 is of particular interest f...
BACKGROUND: Identification of COPD patients with a rapid decline in FEV1 is of particular interest f...
Study objectives: Patients with COPD experience lower airway and systemic inflammation, and an accel...
SummaryBackgroundRecent studies show that COPD patients exhibit low-grade systemic inflammation, and...
Background: Early identification of patients with COPD and prone to more rapid decline in lung funct...
Background: Characterization of COPD patients with rapid lung functional decline is of interest for ...
Early identification of patients with COPD and prone to more rapid decline in lung function is of pa...
Introduction: There is considerable controversy on the possible predictors of lung function decline ...
Background:\ud Chronic Obstructive Pulmonary Disease (COPD) is a progressive disease resulting from ...
Background: Chronic obstructive pulmonary disease (COPD) is major cause of morbidity and mortality w...
Background: The major marker utilized to monitor COPD patients is forced expiratory volume in one se...
BACKGROUND: Change in forced expiratory volume in one second (FEV1) is important for defining severi...
Introduction/Aim: Chronic obstructive pulmonary disease (COPD) is a significant and increasing publi...
Inflammatory biomarkers are considered by modern researchers as one of the best markers of effective...
Background: COPD phenotypes have been identified according to patient clinical characteristics and, ...